Spots Global Cancer Trial Database for resectable gastric or gastroesophageal junction adenocarcinoma
Every month we try and update this database with for resectable gastric or gastroesophageal junction adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma | NCT04221555 | Resectable Gast... | Docetaxel, Oxal... Durvalumab and ... | 19 Years - | Asan Medical Center | |
Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma | NCT04221555 | Resectable Gast... | Docetaxel, Oxal... Durvalumab and ... | 19 Years - | Asan Medical Center |